Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Sandoz Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (682)
Cancellation by sponsor (321)
Prescription medicine registration (54)
Section 14, TGO91 consent (17)
Cancellation or suspension (8)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)

Date

2024 (82)
2023 (78)
2022 (67)
2021 (121)
2020 (153)
2019 (53)
2018 (60)
2017 (50)
2016 (4)
2015 (39)
2014 (20)
2013 (24)
2012 (13)
2011 (51)
2010 (47)
2009 (37)
2008 (27)
2007 (21)
2006 (21)
2005 (54)
2004 (12)
2003 (10)
2002 (10)
2001 (6)
2000 (5)
1999 (5)
1998 (9)
1997 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

1087 result(s) found, displaying 361 to 370

ROSUVASTATIN SANDOZ rosuvastatin (as calcium) 20 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

4 September 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ROSUVASTATIN SANDOZ rosuvastatin (as calcium) 10 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

4 September 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ISOMONIT Isosorbide mononitrate 60mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

4 September 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
OXYTOCIN SANDOZ oxytocin 5IU/1mL injection ampoule Cancelled under Section 30(1)(c) of the Act

4 September 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
POSACONAZOLE SANDOZ posaconazole 100 mg modified release tablet blister pack (319352)

3 March 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for POSACONAZOLE SANDOZ posaconazole 100 mg modified release tablet blister pack.
TAMSULOSIN GX SR tamsulosin hydrochloride 400 microgram prolonged release tablet Cancelled under Section 30(1)(c) of the Act

1 September 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
SITAGLIPTIN AND METFORMIN SANDOZ (Sandoz Pty Ltd)

19 August 2021

Prescription medicine registration

Active ingredients: metformin hydrochloride; sitagliptin hydrochloride monohydrate.
SITAGLIPTIN AND METFORMIN SANDOZ (Sandoz Pty Ltd)

19 August 2021

Prescription medicine registration

Active ingredients: metformin hydrochloride; sitagliptin hydrochloride monohydrate.
ESOMEPRAZOLE SZ esomeprazole (as magnesium) 20 mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

5 August 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ESOMEPRAZOLE SZ esomeprazole (as magnesium) 40 mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

5 August 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd

Pages

First page
Previous page
…
Page 33
Page 34
Page 35
Page 36
Current page 37
Page 38
Page 39
Page 40
Page 41
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.